A Gamechanger for Extending Life Expectancy. The Gilead and Tempus AI Collaboration.
- Jonathan Poyer
- 2 days ago
- 1 min read
Tempus AI (Nasdaq: TEM) manages one of the largest libraries of clinical records.
They use their vast amount of data to identify mutations to target disease and connect the right patients to life-saving clinical trials via AI. The future of medicine is data-driven.
Comments